Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Medical Educational Grant - Johnson & Johnson Innovative Medicine

    Medical Educational Grant - Johnson & Johnson Innovative Medicine supports healthcare educators’ independent continuing medical education to strengthen professional knowledge and improve equitable patient care.

    Browse similar grants
    Cancer Research Grants 2026New Research Grants This Month
    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant was recently updated

    The funder removed the Multiple Myeloma Education RFP listing with its August 31, 2026 deadline; the change does not explicitly announce closure. Educational priorities expanded to include bipolar disorder, pediatric topics, Sjögren’s disease, and warm autoimmune hemolytic anemia (wAIHA), with other neuroscience and immunology priorities also revised.

    Funder: Johnson & Johnson Innovative Medicine

    Due Dates: No general application deadline specified

    Funding Amounts: Not specified

    Summary: Supports independent continuing medical education that strengthens healthcare professionals’ knowledge, improves patient care, and advances equitable healthcare.

    Key Information: Support is for organizations providing independent continuing medical education for healthcare professionals.


    Description

    Johnson & Johnson Innovative Medicine provides medical educational grants to organizations offering independent continuing medical education for healthcare professionals, including physicians, nurses, residents, and pharmacists. The program aims to strengthen professional knowledge and skills, improve patient care, and build a more inclusive and connected health system. Priority is given to therapeutic areas of interest and initiatives serving communities facing barriers to equitable healthcare access and representation.

    Current interests span neuroscience, oncology, immunology, and autoantibody-related conditions. Education may address disease recognition and diagnosis, treatment mechanisms, clinical evidence, treatment selection and sequencing, safety, and adverse-event management. Other priorities include shared decision-making, continuity and coordination of care, underserved populations, and patient quality of life. Supported formats depend on the therapeutic area.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.